289 related articles for article (PubMed ID: 24713399)
1. Brain-derived neurotrophic factor blood levels are decreased in schizophrenia patients and associate with rs6265 genotypes.
Zakharyan R; Boyajyan A
Clin Biochem; 2014 Aug; 47(12):1052-5. PubMed ID: 24713399
[TBL] [Abstract][Full Text] [Related]
2. Association of circulating BDNF levels with BDNF rs6265 polymorphism in schizophrenia.
Kumar PK; Mitra P; Ghosh R; Sharma S; Nebhinani N; Sharma P
Behav Brain Res; 2020 Sep; 394():112832. PubMed ID: 32726665
[TBL] [Abstract][Full Text] [Related]
3. Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics.
Tan YL; Zhou DF; Cao LY; Zou YZ; Zhang XY
Neurosci Lett; 2005 Jul 1-8; 382(1-2):27-32. PubMed ID: 15911116
[TBL] [Abstract][Full Text] [Related]
4. Nerve growth factor and brain-derived neurotrophic factor concentrations in schizophrenia: a review.
Martinotti G; Di Iorio G; Marini S; Ricci V; De Berardis D; Di Giannantonio M
J Biol Regul Homeost Agents; 2012; 26(3):347-56. PubMed ID: 23034254
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine.
Yamamori H; Hashimoto R; Ishima T; Kishi F; Yasuda Y; Ohi K; Fujimoto M; Umeda-Yano S; Ito A; Hashimoto K; Takeda M
Neurosci Lett; 2013 Nov; 556():37-41. PubMed ID: 24141084
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder.
Gama CS; Andreazza AC; Kunz M; Berk M; Belmonte-de-Abreu PS; Kapczinski F
Neurosci Lett; 2007 Jun; 420(1):45-8. PubMed ID: 17442489
[TBL] [Abstract][Full Text] [Related]
7. BDNF Val66Met homozygosity does not influence plasma BDNF levels in healthy human subjects.
Luykx JJ; Boks MP; Breetvelt EJ; Aukes MF; Strengman E; da Pozzo E; Dell'osso L; Marazziti D; van Leeuwen A; Vreeker A; Abramovic L; Martini C; Numans ME; Kahn RS; Ophoff RA
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():185-7. PubMed ID: 23269345
[TBL] [Abstract][Full Text] [Related]
8. Associations between brain-derived neurotrophic factor G196A gene polymorphism and clinical phenotypes in schizophrenia patients.
Huang TL; Lee CT
Chang Gung Med J; 2007; 30(5):408-13. PubMed ID: 18062171
[TBL] [Abstract][Full Text] [Related]
9. Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics.
Xiu MH; Hui L; Dang YF; Hou TD; Zhang CX; Zheng YL; Chen DC; Kosten TR; Zhang XY
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1508-12. PubMed ID: 19720106
[TBL] [Abstract][Full Text] [Related]
10. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment.
Pirildar S; Gönül AS; Taneli F; Akdeniz F
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):709-13. PubMed ID: 15276697
[TBL] [Abstract][Full Text] [Related]
11. BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia.
Zhang XY; Zhou DF; Wu GY; Cao LY; Tan YL; Haile CN; Li J; Lu L; Kosten TA; Kosten TR
Neuropsychopharmacology; 2008 Aug; 33(9):2200-5. PubMed ID: 17987059
[TBL] [Abstract][Full Text] [Related]
12. Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia.
Koolschijn PC; van Haren NE; Bakker SC; Hoogendoorn ML; Hulshoff Pol HE; Kahn RS
Hippocampus; 2010 Sep; 20(9):1010-7. PubMed ID: 19714565
[TBL] [Abstract][Full Text] [Related]
13. [Association study of brain-derived neurotrophic factor Val66Met polymorphism and clinical characteristics of first episode schizophrenia].
Sun MM; Liu LF; Yang LM; Wang Y; Cui KY; Wang LN; Li CL; Qiao DD; Wang RZ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):155-8. PubMed ID: 22487823
[TBL] [Abstract][Full Text] [Related]
14. Decreased levels of serum brain-derived neurotrophic factor in drug-naïve first-episode schizophrenia: relationship to clinical phenotypes.
Chen DC; Wang J; Wang B; Yang SC; Zhang CX; Zheng YL; Li YL; Wang N; Yang KB; Xiu MH; Kosten TR; Zhang XY
Psychopharmacology (Berl); 2009 Dec; 207(3):375-80. PubMed ID: 19787338
[TBL] [Abstract][Full Text] [Related]
15. BDNF serum concentrations in first psychotic episode drug-naïve schizophrenic patients: associations with personality and BDNF Val66Met polymorphism.
Sotiropoulou M; Mantas C; Bozidis P; Marselos M; Mavreas V; Hyphantis T; Antoniou K
Life Sci; 2013 Mar; 92(4-5):305-10. PubMed ID: 23333821
[TBL] [Abstract][Full Text] [Related]
16. Association of serum brain-derived neurotrophic factor and duration of untreated psychosis in first-episode patients with schizophrenia.
Rizos EN; Michalopoulou PG; Siafakas N; Stefanis N; Douzenis A; Rontos I; Laskos E; Kastania A; Zoumpourlis V; Lykouras L
Neuropsychobiology; 2010; 62(2):87-90. PubMed ID: 20523079
[TBL] [Abstract][Full Text] [Related]
17. Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: a positive correlation.
Pedrini M; Chendo I; Grande I; Lobato MI; Belmonte-de-Abreu PS; Lersch C; Walz J; Kauer-Sant'anna M; Kapczinski F; Gama CS
Neurosci Lett; 2011 Mar; 491(3):207-10. PubMed ID: 21256922
[TBL] [Abstract][Full Text] [Related]
18. Val66Met functional polymorphism and serum protein level of brain-derived neurotrophic factor (BDNF) in acute episode of schizophrenia and depression.
Skibinska M; Groszewska A; Kapelski P; Rajewska-Rager A; Pawlak J; Dmitrzak-Weglarz M; Szczepankiewicz A; Twarowska-Hauser J
Pharmacol Rep; 2018 Feb; 70(1):55-59. PubMed ID: 29331787
[TBL] [Abstract][Full Text] [Related]
19. Functional variants of the genes involved in neurodevelopment and susceptibility to schizophrenia in an Armenian population.
Zakharyan R; Boyajyan A; Arakelyan A; Gevorgyan A; Mrazek F; Petrek M
Hum Immunol; 2011 Sep; 72(9):746-8. PubMed ID: 21641949
[TBL] [Abstract][Full Text] [Related]
20. The interplay between BDNF and oxidative stress in chronic schizophrenia.
Zhang XY; Chen DC; Tan YL; Tan SP; Wang ZR; Yang FD; Okusaga OO; Zunta-Soares GB; Soares JC
Psychoneuroendocrinology; 2015 Jan; 51():201-8. PubMed ID: 25462893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
